ATP7B and ovarian cancer: Although ATP7B expression and trafficking provided a significant contribution to cisplatin tolerance in ovarian cancer cells tested, it is likely that other mechanisms are involved in Pt-resistance because cisplatin treatment usually causes complex and multifactorial cellular responses [2].